CN Patent

CN102863512B — 抗病毒化合物

Assigned to Shanghai Hongbo Zhiyuan pharmaceutical Limited by Share Ltd · Expires 2016-04-20 · 10y expired

What this patent protects

本发明涉及如通式I所示结构的化合物，或其对映体、非对映体、共振体，或药学上可接受的盐或溶剂化物，其中的符号在本说明书中都有定义；用其药学组份类似的化合物来治疗或预防病毒感染例如治疗类似HIV的病毒。

USPTO Abstract

本发明涉及如通式I所示结构的化合物，或其对映体、非对映体、共振体，或药学上可接受的盐或溶剂化物，其中的符号在本说明书中都有定义；用其药学组份类似的化合物来治疗或预防病毒感染例如治疗类似HIV的病毒。

Drugs covered by this patent

bictegravir-sodium (BICTEGRAVIR SODIUM)

Patent Metadata

Patent number: CN102863512B
Jurisdiction: CN
Classification: —
Expires: 2016-04-20
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Hongbo Zhiyuan pharmaceutical Limited by Share Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.